跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMULDOSA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
IMULDOSA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
IMULDOSA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Accord Healthcare S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 10, 2025
Approval ID
28a587fcf953bb2b
Company
Accord Healthcare S.L.U.
Type
Standard
Approval Details
Approval Id
28a587fcf953bb2b
Drug Cima Aemps Name
IMULDOSA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1241872003
Holder Company Name
Accord Healthcare S.L.U.
Marketing Company Name
Accord Healthcare S.L.U.
Holder Company Detail Path
/organization/accord-healthcare-sl
Marketing Company Detail Path
/organization/accord-healthcare-sl
Authorization Date
2025-01-10
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
130 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Accord Healthcare S.L.U.
Company Detail Path
/organization/accord-healthcare-sl
Company Information
Pharmaceutical Company Name
ACCORD HEALTHCARE SL
Country Name
Spain
City Name
barcelona,barcelona,country_es
Address
CALLE MOLL BARCELONA (WORLD TRADE CENTER EDIF. ESTE), S/N
Active Ingredients
USTEKINUMAB
5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 10, 2025
Approval ID
28a587fcf953bb2b
Type
Standard
Back to CIMA-AEMPS Approvals